Regulatory & Legal

A new partnership aims to unify cybersecurity and operations in smart buildings, but can it solve the deep-rooted trust and vulnerability issues?

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

India's new Labour Code 2025 is forcing a strategic pivot. Discover how firms are turning regulatory mandates into a competitive edge for productivity.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

MediWound's burn treatment now prevents traumatic tattoos from blasts and accidents, signaling a major strategic expansion and a new era in trauma care.

As AI fuels a new arms race in cyberspace, an innovative training model emerges to arm human defenders. Is this the future of cybersecurity education?

CEO Amy Perry’s influence is celebrated, but her true test is securing Banner’s vast, AI-driven ecosystem from the escalating threats of the digital age.

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

Apollo Commercial Real Estate Finance offers a tempting 10% yield, but can it last? We dive into the risks and rewards of this high-stakes CRE play.

Grant Eason's promotion to Managing Director reveals more than a career move; it's a key to Capital Southwest's strategy in the heated private credit market.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

A new report shows a startling drop in dental benefits, revealing deep cracks in America's health system and new economic pressures on employers.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

The fight for STAAR Surgical heats up. Alcon's new $1.6B offer isn't enough for its largest shareholder, who alleges a deeply conflicted sales process.

iDEAL's grip on Dutch iGaming isn't just about payments. Explore how trust, regulation, and tech created a unique digital fortress for online casinos.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.